Understanding the Expanding Role of Biosimilars in Quality Cancer Care
  • Program Overview
    Understanding the Expanding Role of Biosimilars in Quality Cancer Care
    Our expert faculty members Gary H. Lyman, MD, MPH, FASCO, FRCP (Edin); Jeffrey Crawford, MD; and Rowena Schwartz, PharmD, BCOP, explore the expanding role of biosimilars in supportive and therapeutic cancer care in these downloadable slidesets and archived Webcast from our Chicago satellite symposium presented in partnership with National Comprehensive Cancer Network® (NCCN®).
  • Featured content
    In this slideset, Gary Lyman, MD, MPH, FASCO, discusses the promise and challenges of incorporating oncology biosimilars into clinical practice.
    Date Posted: 6/9/2017
  • 1
  • 2

Latest Content

3 of 3 Shown
3 of 3 Shown
Show 0 More
Loading...